PRKDC and amyotrophic lateral sclerosis: Given the above observations, the activation of DNA-PK and the control of the corresponding signaling pathway by the compounds found in this study might provide critical tools to mitigate FUS-specific condensation and aggregation, thereby ameliorating FUS-ALS pathology.